Page last updated: 2024-08-23

paclitaxel and Barrett Epithelium

paclitaxel has been researched along with Barrett Epithelium in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, J; Corrie, P; di Pietro, M; Fitzgerald, RC; Januszewicz, W; Liu, H1
Becker, K; Bekesch, M; Busch, R; Ewald, P; Feith, M; Höfler, H; Langer, R; Sarbia, M; Siewert, JR; Specht, K; Stein, HJ1
Nguyen, DM; Schrump, DS1
Becker, K; Busch, R; Ewald, P; Feith, M; Höfler, H; Langer, R; Sarbia, M; Siewert, JR; Specht, K; Stein, HJ1
Chen, KT1
D'Amico, TA; Harpole, DH1

Reviews

2 review(s) available for paclitaxel and Barrett Epithelium

ArticleYear
Novel molecular targeted therapy for esophageal cancer.
    Journal of surgical oncology, 2005, Dec-01, Volume: 92, Issue:3

    Topics: Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Transformation, Neoplastic; Clinical Trials as Topic; Depsipeptides; DNA Methylation; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glycoproteins; Histone Deacetylase Inhibitors; Humans; Mitogen-Activated Protein Kinases; Paclitaxel; Protein Kinase C; Signal Transduction

2005
Molecular biology of esophageal cancer.
    Chest surgery clinics of North America, 2000, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Barrett Esophagus; Biomarkers, Tumor; Carcinoma, Squamous Cell; DNA Damage; Esophageal Neoplasms; Genes, p53; Humans; Incidence; Mutation; Paclitaxel; Prognosis; Risk Factors

2000

Other Studies

4 other study(ies) available for paclitaxel and Barrett Epithelium

ArticleYear
A sinister black finding in the stomach.
    Lancet (London, England), 2019, Mar-16, Volume: 393, Issue:10176

    Topics: Acrylonitrile; Aged; Aniline Compounds; Barrett Esophagus; Benzimidazoles; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Melanoma; Mutation; Neoplasm Metastasis; Paclitaxel; Prognosis; Stomach; Tomography, X-Ray Computed; Tubulin Modulators; Uveal Neoplasms

2019
Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-15, Volume: 11, Issue:20

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Calmodulin-Binding Proteins; Cisplatin; Combined Modality Therapy; DNA-Binding Proteins; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multidrug Resistance-Associated Proteins; Neoadjuvant Therapy; Paclitaxel; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Time Factors; Treatment Outcome

2005
[Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 2004, Volume: 88

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cisplatin; DNA Primers; Esophageal Neoplasms; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Neoadjuvant Therapy; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction

2004
Cytology of small-cell carcinoma arising in Barrett's esophagus.
    Diagnostic cytopathology, 2000, Volume: 23, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cytodiagnosis; Esophageal Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Treatment Outcome

2000